|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
731750306 |
| 003 |
DE-627 |
| 005 |
20230905072044.0 |
| 007 |
tu |
| 008 |
121211s2013 xxk||||| 00| ||eng c |
| 010 |
|
|
|a 2012047645
|
| 020 |
|
|
|a 9780702042904
|9 978-0-7020-4290-4
|
| 020 |
|
|
|a 9780702042911
|c International
|9 978-0-7020-4291-1
|
| 035 |
|
|
|a (DE-627)731750306
|
| 035 |
|
|
|a (DE-599)GBV731750306
|
| 035 |
|
|
|a (OCoLC)862803354
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-GB
|c XD-US
|c XE-AU
|
| 050 |
|
0 |
|a RS200
|
| 060 |
|
0 |
|a QV 786
|
| 082 |
0 |
|
|a 615.1/9
|q LOC
|2 23
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a VX 5010
|q BVB
|2 rvk
|0 (DE-625)rvk/147794:
|
| 084 |
|
|
|a 58.28
|2 bkl
|
| 245 |
1 |
0 |
|a Aulton's pharmaceutics
|b the design and manufacture of medicines
|c ed. by Michael E. Aulton and Kevin M.G. Taylor
|
| 246 |
1 |
|
|i Nebent.
|a Pharmaceutics
|
| 250 |
|
|
|a 4th ed.
|
| 263 |
|
|
|a 1306
|
| 264 |
|
1 |
|a Edinburgh [u.a.]
|b Churchill Livingstone/Elsevier
|c 2013
|
| 300 |
|
|
|a XIII, 894 S.
|b Ill., graph. Darst.
|c cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 650 |
|
2 |
|a Dosage Forms
|
| 650 |
|
2 |
|a Biopharmaceutics
|x methods
|
| 650 |
|
2 |
|a Drug Compounding
|x methods
|
| 650 |
|
2 |
|a Drug Design
|
| 650 |
|
4 |
|a Biopharmaceutics
|x methods
|
| 650 |
|
4 |
|a Dosage Forms
|
| 650 |
|
4 |
|a Drug Compounding
|x methods
|
| 650 |
|
4 |
|a Drug Design
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Aulton, Michael E.
|4 oth
|
| 700 |
1 |
|
|a Taylor, Kevin M. G.
|4 oth
|
| 776 |
1 |
|
|z 9780702053931
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/731750306.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|v 2013-07-18
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a ISIL_DE-27
|
| 936 |
r |
v |
|a VX 5010
|b Lehrbücher
|k Chemie und Pharmazie
|k Pharmazeutische Technologie einschl. Biopharmazie
|k Pharmazeutische Technologie allgemein
|k Lehrbücher
|0 (DE-627)1271592819
|0 (DE-625)rvk/147794:
|0 (DE-576)201592819
|
| 936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 615.1/9
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 1378124626
|c 00
|f MAG
|d 2280-3887
|e --%%--
|j --%%--
|y k
|z 08-07-13
|
| 980 |
|
|
|2 31
|1 01
|x 0027
|b 1646573021
|c 00
|f LBS/J 26
|d LBS:PHA:RB:5010:Aul:2013
|e c
|j --%%--
|y z
|z 14-11-16
|
| 980 |
|
|
|2 31
|1 02
|x 0027
|b 1650286805
|c 00
|f LBS/J 26
|d LBS:PHA:RB:5010:Aul:2013
|e c
|j --%%--
|y z
|z 09-12-16
|
| 980 |
|
|
|2 31
|1 03
|x 0027
|b 1650286813
|c 00
|f LBS/J 26
|d LBS:PHA:RB:5010:Aul:2013
|e c
|j --%%--
|y z
|z 09-12-16
|
| 980 |
|
|
|2 31
|1 04
|x 0027
|b 1650286821
|c 00
|f LBS/J 26
|d LBS:PHA:RB:5010:Aul:2013
|e c
|j --%%--
|y z
|z 09-12-16
|
| 980 |
|
|
|2 31
|1 05
|x 0027
|b 165028683X
|c 00
|f J 36
|d PHA:RB:5010:Aul::2013
|e d
|j --%%--
|y z
|z 09-12-16
|
| 983 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a PHA:RB:5010
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$029280665
|
| 984 |
|
|
|2 31
|1 01
|x 0027
|a 27$030259959
|
| 984 |
|
|
|2 31
|1 02
|x 0027
|a 27$030259525
|
| 984 |
|
|
|2 31
|1 03
|x 0027
|a 27$030259533
|
| 984 |
|
|
|2 31
|1 04
|x 0027
|a 27$030259940
|
| 984 |
|
|
|2 31
|1 05
|x 0027
|a 27$030260116
|
| 985 |
|
|
|2 20
|1 01
|x 0084
|a 2928066
|
| 985 |
|
|
|2 31
|1 01
|x 0027
|a U524937/1
|
| 985 |
|
|
|2 31
|1 02
|x 0027
|a U524937/2
|
| 985 |
|
|
|2 31
|1 03
|x 0027
|a U524937/3
|
| 985 |
|
|
|2 31
|1 04
|x 0027
|a U524937/4
|
| 985 |
|
|
|2 31
|1 05
|x 0027
|a U524936
|
| 998 |
|
|
|2 31
|1 01
|x 0027
|a PHA 201612
|
